- Who can participate: Eligible participants are adults aged 18 to 65 who have been diagnosed with chronic pain for at least six months. Exclusion criteria include recent surgery or participation in another clinical trial within the past 30 days.
- Study details: Participants will be required to take the investigational medication daily and attend regular clinic visits for assessments, including pain evaluation and safety monitoring.